BioNano Genomics Inc (NASDAQ: BNGO) Is Included In Small-Cap Russell 2000® Index, Ashford Hospitality Trust, Inc. (NYSE: AHT) Preparing To Be Included In The Russell 2000®, Russell 3000® And Russell Microcap® Indexes

BioNano Genomics Inc (NASDAQ: BNGO) has made it official that it has found a place in the U.S. small-cap Russell 2000® Index. Companies that make it to the list are eligible to be members for one year. BioNano Genomics Inc is a genome analysis company that supports scientists with the tools in clinicians conducting genetic research, patient testing, and diagnostic testing for patients diagnosed with Autism Spectrum Disorder (ASD) and…

Read More >>

While Lineage Cell Therapeutics Inc (NYSEAMERICAN: LCTX) In Russell 3000® and Russell Microcap® Indexes, Inpixon (NASDAQ: INPX) Included In The Russell Microcap® Index

Lineage Cell Therapeutics Inc (NYSEAMERICAN: LCTX), a clinical-stage biotechnology company involved in developing allogeneic cell therapies for unmet medical needs, in an official statement, announced that the company had made it to broad-market Russell 3000® Index as well as the Russell Microcap® Index. Inpixon (NASDAQ: INPX) included in Russell Microcap® Index Inpixon (NASDAQ: INPX), the Indoor Intelligence™ company, announced that it had made it to the Russell Microcap® Index. By…

Read More >>

IJP Corporation (OTCMKTS:IJJP) stock Is Down 20%: What’s Going On?

In the past week, the IJP Corporation (OTCMKTS:IJJP) stock has suffered from a pretty strong selloff and declined by as much as 20% during the period. In this regard, it might be a good time for investors to start looking into some of the recent development with regards to the company. Yesterday, the company noted that its Pink Current Information status is still in the final stage of review with…

Read More >>

Caladrius Biosciences Inc. (NASDAQ: CLBS) Jumps 4.5% After FDA Approves Its CLBS201 IND in Diabetic Kidney Disease

Caladrius Biosciences Inc. (NASDAQ: CLBS) climbed 4.46% after the FDA approved its Investigational New Drug Application for the CLBS201 study. CLBS201 is a CD34+ cell therapy for diabetic kidney disease treatment.  Caladrius evaluating CLBS20’s efficacy and safety  David J. Mazzo, the company’s CEO and President said, “Our latest development program, CLBS201, is designed to assess the safety and efficacy of CD34+ cell therapy as a treatment for diabetic patients with…

Read More >>

Antares Pharma Inc. (NASDAQ: ATRS) Submits IND for ATRS-1902 Clinical Study In Adrenal Crisis Management

Antares Pharma Inc. (NASDAQ: ATRS) has announced an Investigational New Drug Application to the FDA to commence its Phase 1 ATRS-1902 clinical study to treat adrenal crisis rescue.  Adrenal crisis is associated with cortisol deficiency  The ATRS-1902 application and corresponding development program support proposed acute adrenal insufficiency (adrenal crisis) treatment using a new proprietary auto-injector delivery platform for hydrocortisone.  Dr. Peter Richardson, Antares Pharma EVP R&D, and Chief Medical Officer…

Read More >>

Lineage Cell Therapeutics Inc. (NYSEAMERICAN: LCTX) Gains After FDA Gives Feedback On OPC1 IND

Lineage Cell Therapeutics Inc. (NYSEAMERICAN: LCTX) gained 2.16% after releasing an update in OPC1’s clinical development. OPC1 is the company’s experimental allogeneic oligodendrocyte progenitor cell (OPC) transplant therapy for spinal cord injury treatment.  Lineage receives FDA feedback on OPC1 IND Last week the company received feedback from the FDA under the US FDA’s Regenerative Medicine Advanced Therapy program. As a result, Lineage is planning to submit an amendment to its…

Read More >>

Lineage Cell Therapeutics Inc (NYSEAMERICAN: LCTX) Brings Onboard Kevin Cook To Serve As The Company’s Chief Financial Officer

Lineage Cell Therapeutics Inc (NYSEAMERICAN: LCTX) is quite pleased to make Kevin Cook its new Chief Financial Officer, effective June 21, 2021. It believes that the official will greatly contribute to its efforts to grow and become a top cell therapy and cell Transplant Company. The company considered Cook’s qualifications and track record The company chose Cook after considering the value he would bring to its business. That starts with his…

Read More >>

Borqs Technologies Inc (NASDAQ: BRQS) To Supply Android Based Handheld Computers To Several Markets

Borqs Technologies Inc (NASDAQ: BRQS) is set to supply Android-based handheld computers to the E.U., U.S., and Asian markets. The opportunity comes following the company’s successful landing of purchase orders from U.S. Fortune 500 Company.  Company’s operations Borqs hopes to channel in significant revenue streams with the development of rugged handheld computers. The company employs some key technologies in its manufacturing endeavors. It uses the integrated scanner and radio bands in…

Read More >>

World’s Debut 35,000-nit HRD Green OLED Microdisplay Produced Courtesy Kopin Corporation (NASDAQ: KOPN)

Kopin Corporation (NASDAQ: KOPN), a company that is regarded as one of the leading developers and provider of high-resolution micro-displays, display subassemblies, and systems, has in a statement made an official announcement that it has successfully produced what is called high-dynamic-range (HDR), green Organic Light Emitting Diode (OLED) microdisplay on silicon. The company is involved in developing and producing high-resolution microdisplays, display subassemblies, and systems used in various sectors, including…

Read More >>

Hop-On Inc (HPNN) Stock Consolidates After The Big Jump: What Next?

After the company made a major announcement with regards to its decentralized social media platform digitalage.com this morning, the Hop-On Inc (OTCMKTS:HPNN) stock has actually declined and gone down by 4%. However, at the same time, it is also necessary for investors to keep in mind that over the course of the past week the stock has clocked gains of as much as 60%. This morning the company announced that…

Read More >>